WADA Releases 2026 Annual Report: Testing Volume Rises, but the Growth Curve Is Flattening and a Funding Gap Opens

At every swim meet there is a stretch of time that never appears on the scoreboard. An athlete has just climbed out of the water, hair still dripping, a towel thrown over her shoulders, sitting on a plastic chair in a hallway waiting for the doping control officer. Spectators never see that wait. Coaches see all of it: a girl who has just finished the 400m individual medley has to rehydrate, has to file her whereabouts for the next three months, and has to live with the possibility of a knock on her hotel door at six in the morning in a city a ten-hour flight from home.

The World Anti-Doping Agency's 2026 annual report is the ledger of thousands of hallways like that one. WADA reports 297,965 samples collected in 2026, roughly 9,100 more than the 288,865 samples of 2026. That is the highest figure in the 2026–2026 series the agency publishes alongside a chart.

The notable part is the pace. From 2026 to 2026 total samples rose 12.5%. From 2026 to 2026 the increase was just 3.2%. The expansion is decelerating sharply, even as the report's framing still carries a growth tone. The curve loads forward and then flattens, a shape familiar from systems that have hit a resource ceiling.

The adverse analytical finding (AAF) rate has barely moved: 0.77% in 2026, 0.80% in 2026, 0.78% in 2026. The three-year band is roughly 0.03 percentage points. A detection rate stable at around 0.78% is the most robust data in the entire document — stable enough to treat as a baseline rather than statistical noise.

In substance this is a governance document, not a results bulletin. It bundles three strands: compliance audits of national anti-doping organizations, WADA's finances, and progress toward the 2027 edition of the World Anti-Doping Code. For people in swimming, the first two matter most, because they determine whether an athlete is tested consistently at all. One technical note: the report is labelled 2026 but its testing data stop at 2026, a publication lag of roughly one year. When citing it, quote the internal percentages rather than the headline.

WADA ran nine compliance audits in the period. Average non-conformities fell from 25.5 to 20. Broken down by category, though, the picture reverses: testing-related non-conformities rose 11%, made up 45% of all findings, and 23% of those were rated critical. The system's biggest problem sits in sample collection, not in the athletes themselves. It must also be said that nine audits are far too small a sample for global conclusions, so the improvement from 25.5 to 20 reads as a weak signal, while the 11% rise in testing deficiencies is a strong one because it measures operational capacity directly.

In another direction, WADA and its Athlete Council ran consultations with more than 600 athletes and commission representatives from over 60 countries and more than 70 sports. When the stands are empty, our community starts knocking on doors. That is a legitimacy-building effort for the new code. The document does not say whether athlete input changed any specific provision, so this can only be recorded for scale, not assessed for impact.

The 2027 Code and International Standards were adopted in Busan, South Korea, and take effect on January 1, 2027. A quiet signature, but one that can rewrite an entire ecosystem. The period between now and that date is a transition window in which national organizations keep operating by old habits while waiting for the new rules.

The financial section is the most troubling. WADA reports a shortfall of 8.3 million USD against its expected budget. The United States has not paid 3.8 million USD; Russia owes 3.9 million USD. At the same time the agency reports a net surplus of 1.2 million USD. Running both a surplus and a shortfall implies spending is being tightened or deferred — and in an organization whose core activity is collecting samples, tightening usually lands on sample numbers. In parallel, WADA describes a shift from traditional testing toward investigations and prevention: more than 250 investigative operations, 88 laboratories dismantled, more than 90 tonnes of substances seized. That approach targets the organizations behind doping rather than individual athletes alone.

For swimming, this story has its own colour. Swimming is sample-hungry: a national championship can generate hundreds of samples in a week because there are many events, many entrants, and overlapping pre-competition, in-competition and post-competition requirements. When a country's anti-doping budget is cut, where does it cut first? Usually out-of-competition testing — the most expensive kind, because it means travelling to training sites, to places where no spectator and no sponsorship contract is watching.

Over years spent in the stands and press rooms of swim meets, I have noticed a detail rarely discussed: strong delegations have dedicated staff tracking each athlete's whereabouts day by day, while smaller delegations leave filing to the coach. That staffing gap never shows on a results sheet, but it determines whether a young athlete is tested on schedule or missed because a whereabouts filing was wrong. With 45% of non-conformities in sample collection and a shortfall of 8.3 million USD, two figures from two different chapters of the same report point in the same direction.

An AAF rate stable at around 0.78% can be read two ways. First, the underlying rate of use is unchanged. Second, the system is targeting better, so positivity holds steady even as sample numbers rise. Public data cannot separate these, and anyone asserting one confidently is inferring more than the document allows.

The counterintuitive point sits here: the biggest threat to clean sport in this cycle is not a new substance but unpaid invoices. When two major contributors let arrears run, the system's testing capacity weakens before any athlete is ever sanctioned. A test that never happens will never appear in any statistic, including statistics about tests.

Reading more testing as cleaner sport is also statistically wrong. Sample volume is an input, not an output. A large collection programme spread evenly can detect less than a smaller one aimed precisely. WADA's pivot toward investigations and prevention suggests the agency itself recognizes this, and it is also why a slowing sample curve is not necessarily bad news.

One question remains unanswered: who audits the auditor? The 2027 Code has teeth, but those teeth are sharpened with money the agency does not fully control. If late payment becomes the norm, enforcement weakens exactly where it is needed most — in under-resourced federations, where young athletes are least able to protect themselves.

January 1, 2027 is a fixed milestone. Enforcement capacity is not. Behind the numbers are women who refuse to stop — who still get in the pool at five in the morning, still file their whereabouts correctly, still open a hotel room door to a stranger holding a sample kit. What they need is not a larger testing programme on paper. They need a testing programme funded well enough to actually happen.